PAMP
MYGN icon

Polar Asset Management Partners’s Myriad Genetics MYGN Stock Holding History

Polar Asset Management Partners’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-350,000
Closed -$8.22M – 191
2013
Q3 		$8.22M Buy
+350,000
New +$9.94M 0.35% 78

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Polar Asset Management Partners's MYGN Position: Q3 2023 in Review

Polar Asset Management Partners sold out of Myriad Genetics (MYGN) in Q3 2023, closing a stake of 166,057 shares — an estimated $3.85M sold.

Polar Asset Management Partners first reported a position in MYGN in Q3 2021 and held it in 7 quarters. The position peaked at $21.4M in Q2 2022. 186 funds tracked by Wall St. Rank hold MYGN as of Q3 2023.

  • Polar Asset Management Partners reported no remaining Myriad Genetics position as of Q3 2023 after selling out during the quarter.
  • Polar Asset Management Partners sold 166,057 Myriad Genetics shares in Q3 2023, an estimated $3.85M.
  • Polar Asset Management Partners first reported a position in Myriad Genetics in Q3 2021 and held it in 7 quarters.
  • Polar Asset Management Partners's Myriad Genetics position peaked at $21.4M in Q2 2022.
  • 186 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2023.

Based on Polar Asset Management Partners's 13F filing for Q3 2023, filed 14 Nov 2023.